Cite
MLA Citation
Josep Tabernero et al.. “Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.” Lancet oncology, vol. 16, no. 8, n.d., pp. 937–948. http://access.bl.uk/ark:/81055/vdc_100051208996.0x00002f